| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | Dec 13, 2021 | Spyre Therapeutics, Inc. | Director | Buy | 97.5 | +150,000 | 100.00% | ✗ | $549.7K |
| Jul 5, 2017 | Jul 7, 2017 | Rein Therapeutics, Inc. | Director | Buy | 100.0 | +250,000 | 29.59% | ✗ | $3.8M |
| Aug 16, 2016 | Aug 16, 2016 | Protagonist Therapeutics, Inc | Director | Buy | 100.0 | +583,333 | 38.47% | ✗ | $7M |